AAAAAA
Results:
1-8
|
Results: 8
Authors:
GASKIN DJ
KONG J
MEROPOL NJ
YABROFF KR
WEAVER C
SCHULMAN KA
Citation: Dj. Gaskin et al., TREATMENT CHOICES BY SERIOUSLY ILL PATIENTS - THE HEALTH STOCK RISK ADJUSTMENT MODEL, Medical decision making, 18(1), 1998, pp. 84-94
Authors:
SCHULMAN KA
DORSAINVIL D
YABROFF KR
DICESARE J
FELSER J
EISENBERG JM
GLICK HA
Citation: Ka. Schulman et al., PROSPECTIVE ECONOMIC-EVALUATION ACCOMPANYING A TRIAL OF GM-CSF IL-3 IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS AND NON-HODGKINS-LYMPHOMA/, Bone marrow transplantation, 21(6), 1998, pp. 607-614
Authors:
HALPERN MT
YABROFF KR
SLOAN EP
Citation: Mt. Halpern et al., COSTS OF MEDICAL RESOURCE USE ASSOCIATED WITH COMPLICATIONS OF IV DRUG-THERAPY, Formulary, 32(9), 1997, pp. 944
Authors:
BAROFSKY I
YABROFF KR
PEARSON AD
ROTHMAN M
Citation: I. Barofsky et al., CURRENT HEALTH STATE AS A PREDICTOR OF THE PREFERENCES OF METASTATIC PROSTATE-CANCER PATIENTS, Quality of life research, 6(7-8), 1997, pp. 26-26
Authors:
YABROFF KR
BAROFSKY I
PEARSON A
ROTHMAN M
Citation: Kr. Yabroff et al., DETERMINING THE IMPORTANCE OF SPECIFIC SYMPTOMS FOR THE ECONOMIC-EVALUATION OF ADVANCED PROSTATE-CANCER THERAPIES, European journal of cancer, 33, 1997, pp. 33-33
Authors:
YABROFF KR
LINAS BP
SCHULMAN K
Citation: Kr. Yabroff et al., EVALUATION OF QUALITY-OF-LIFE FOR DIVERSE PATIENT POPULATIONS, Breast cancer research and treatment, 40(1), 1996, pp. 87-104
Authors:
SCHULMAN KA
LLANA T
YABROFF KR
Citation: Ka. Schulman et al., ECONOMIC-ASSESSMENT WITHIN THE CLINICAL DEVELOPMENT PROGRAM, Medical care, 34(12), 1996, pp. 89-95
Authors:
SCHULMAN K
YABROFF KR
DICESARE J
FEISER JM
Citation: K. Schulman et al., RESOURCE CONSUMPTION ONE-YEAR FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PHARMACOECONOMIC EVALUATION OF A PHASE-III CLINICAL-TRIAL, Blood, 86(10), 1995, pp. 1589-1589
Risultati:
1-8
|